Tech Company Financing Transactions

Setara Biosciences Funding Round

Setara Biosciences secured a $90 million Series A funding round on 10/30/2026. Investors included Canaan Partners, Deerfield Management Company and Droia Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

11202 El Camino Real 100
San Diego, CA 92130
USA

Phone

Undisclosed

Website

www.setarabiosciences.com

Email Address

Not Recorded

Overview

Setara was formed as a spinout of Actio Biosciences following its acquisition by Jazz Pharmaceuticals. Building on Actio's scientific foundation, Setara combines deep expertise in Mendelian genetics, drug discovery, and data science to develop small-molecule precision medicines that target the underlying causes of disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Goldstein

        

Chief Financial Officer

Cayce Denton

        

Chief Scientific Officer

David Breckenridge

        

VP - Bus. Development

Peter Condon

        

Browse more venture capital transactions:

Prev: 10/30/2026: Neuron Industries venture capital transaction
Next: 10/30/2026: VUSE XR venture capital transaction

Share this article

Where The Data Comes From

We record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary